Harvard Stem Cell Institute and the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts 02139, USA.
Physiol Rev. 2013 Jan;93(1):311-25. doi: 10.1152/physrev.00005.2012.
Regenerative medicine seeks to understand tissue development and homeostasis and build on that knowledge to enhance regeneration of injured tissues. By replenishing lost functional tissues and cells, regenerative medicine could change the treatment paradigm for a broad range of degenerative and ischemic diseases. Multipotent cells hold promise as potential building blocks for regenerating lost tissues, but successful tissue regeneration will depend on comprehensive control of multipotent cells-differentiation into a target cell type, delivery to a desired tissue, and integration into a durable functional structure. At each step of this process, proteins and small molecules provide essential signals and, in some cases, may themselves act as effective therapies. Identifying these signals is thus a fundamental goal of regenerative medicine. In this review we discuss current progress using proteins and small molecules to regulate tissue regeneration, both in combination with cellular therapies and as monotherapy.
再生医学旨在了解组织发育和稳态,并在此基础上增强受损组织的再生。通过补充丢失的功能性组织和细胞,再生医学可能会改变多种退行性和缺血性疾病的治疗模式。多能细胞有望成为再生丢失组织的潜在构建块,但成功的组织再生将取决于对多能细胞的全面控制——分化为靶细胞类型、递送到所需组织以及整合到持久的功能结构中。在这个过程的每一步,蛋白质和小分子提供必需的信号,在某些情况下,它们本身可能就是有效的治疗方法。因此,确定这些信号是再生医学的一个基本目标。在这篇综述中,我们讨论了利用蛋白质和小分子来调节组织再生的最新进展,包括与细胞疗法联合应用和作为单一疗法的应用。